FBT.L vs. BTEE.L
FBT.L (First Trust NYSE Arca Biotechnology UCITS ETF Acc) and BTEE.L (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) are both Health & Biotech Equities funds tracking the NASDAQ Biotechnology TR USD, from First Trust and iShares respectively. Both are passively managed. Over the past 5 years, FBT.L returned 7.17%/yr vs 5.14%/yr for BTEE.L. A 0.60 correlation means they provide meaningful diversification when combined. FBT.L charges 0.60%/yr vs 0.35%/yr for BTEE.L.
Performance
FBT.L vs. BTEE.L - Performance Comparison
Loading charts...
Different Trading Currencies
FBT.L is traded in GBp, while BTEE.L is traded in USD. To make them comparable, the BTEE.L values have been converted to GBp using the latest available exchange rates.
Returns By Period
In the year-to-date period, FBT.L achieves a 4.41% return, which is significantly higher than BTEE.L's 1.62% return.
FBT.L
- 1D
- 1.98%
- 1M
- 8.09%
- YTD
- 4.41%
- 6M
- 1.93%
- 1Y
- 34.35%
- 3Y*
- 9.80%
- 5Y*
- 7.17%
- 10Y*
- —
BTEE.L
- 1D
- 1.11%
- 1M
- 0.46%
- YTD
- 1.62%
- 6M
- -0.29%
- 1Y
- 38.96%
- 3Y*
- 9.52%
- 5Y*
- 5.14%
- 10Y*
- —
FBT.L vs. BTEE.L - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | 4.41% | 17.24% | 7.13% | -0.99% | 3.88% | -2.57% | -2.54% |
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 1.62% | 23.36% | 0.03% | 0.55% | -1.41% | 0.37% | 10.12% |
Correlation
The correlation between FBT.L and BTEE.L is 0.85, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.85 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.64 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.62 |
Correlation (All Time) Calculated using the full available price history since Jun 16, 2020 | 0.61 |
Over the past year, FBT.L and BTEE.L have become more correlated (0.85) than their long-term average of 0.60, meaning their price movements have been converging.
FBT.L vs. BTEE.L - Sectors Allocation Comparison
Sectors
FBT.L
BTEE.L
Healthcare
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
FBT.L
BTEE.L
Basic Materials
FBT.L
-
BTEE.L
-
Communication Services
FBT.L
-
BTEE.L
-
Consumer Cyclical
FBT.L
-
BTEE.L
-
Consumer Defensive
FBT.L
-
BTEE.L
-
Energy
FBT.L
-
BTEE.L
-
Financial Services
FBT.L
-
BTEE.L
-
Industrials
FBT.L
-
BTEE.L
-
Real Estate
FBT.L
-
BTEE.L
-
Technology
FBT.L
-
BTEE.L
-
Utilities
FBT.L
-
BTEE.L
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FBT.L vs. BTEE.L — Risk / Return Rank
FBT.L
BTEE.L
FBT.L vs. BTEE.L - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| FBT.L | BTEE.L | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.30 | ||
| Sortino ratioReturn per unit of downside risk | -0.25 | ||
| Omega ratioGain probability vs. loss probability | 1.29 | 1.34 | -0.04 |
| Calmar ratioReturn relative to maximum drawdown | 2.48 | 5.54 | -3.07 |
| Martin ratioReturn relative to average drawdown | 6.60 | 15.87 | -9.27 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| FBT.L | BTEE.L | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.70 | 2.01 | -0.30 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.45 | 0.25 | +0.20 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.26 | 0.30 | -0.05 |
Drawdowns
FBT.L vs. BTEE.L - Drawdown Comparison
The maximum FBT.L drawdown since its inception was -30.39%, roughly equal to the maximum BTEE.L drawdown of -30.88%. Use the drawdown chart below to compare losses from any high point for FBT.L and BTEE.L.
Loading charts...
Drawdown Indicators
| FBT.L | BTEE.L | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -30.39% | -30.88% | +0.49% |
Max Drawdown (1Y)Largest decline over 1 year | -13.81% | -7.00% | -6.81% |
Max Drawdown (3Y)Largest decline over 3 years | -23.70% | -26.47% | +2.77% |
Max Drawdown (5Y)Largest decline over 5 years | -23.70% | -30.88% | +7.18% |
Current DrawdownCurrent decline from peak | -1.97% | -4.93% | +2.96% |
Average DrawdownAverage peak-to-trough decline | -13.45% | -10.13% | -3.32% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 5.19% | 2.45% | +2.74% |
Volatility
FBT.L vs. BTEE.L - Volatility Comparison
First Trust NYSE Arca Biotechnology UCITS ETF Acc (FBT.L) and iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) (BTEE.L) have volatilities of 6.10% and 6.38%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FBT.L | BTEE.L | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.10% | 6.38% | -0.28% |
Volatility (6M)Calculated over the trailing 6-month period | 15.02% | 14.77% | +0.25% |
Volatility (1Y)Calculated over the trailing 1-year period | 20.11% | 19.41% | +0.70% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.49% | 20.69% | +1.80% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.86% | 22.40% | +1.46% |
FBT.L vs. BTEE.L - Expense Ratio Comparison
FBT.L has a 0.60% expense ratio, which is higher than BTEE.L's 0.35% expense ratio.
Dividends
FBT.L vs. BTEE.L - Dividend Comparison
FBT.L has not paid dividends to shareholders, while BTEE.L's dividend yield for the trailing twelve months is around 0.37%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
BTEE.L iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.37% | 0.37% | 0.46% | 0.39% | 0.44% | 0.25% | 0.17% | 0.14% | 0.07% |
FBT.L First Trust NYSE Arca Biotechnology UCITS ETF Acc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
FBT.L and BTEE.L have a correlation of 0.85, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
On fees, BTEE.L is cheaper at 0.35% per year. The better choice depends on whether you care most about return, fees, risk, or income.
BTEE.L is cheaper with a 0.35% expense ratio, compared with 0.60% for FBT.L.
Both ETFs track NASDAQ Biotechnology TR USD. They also come from different issuers: First Trust and iShares. Their fees differ too: 0.60% for FBT.L and 0.35% for BTEE.L.
Find the right allocation for FBT.L and BTEE.L
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer